'Close doesn't count:' Biomarker testing crucial for modern

One of the most important reasons for the recent improvements in lung cancer treatments is biomarker testing — testing to determine the exact kind of cancer a patient has, in order to enable the most personalized treatment possible.

Related Keywords

Stephen Liu , National Cancer Institute , National Cancer , Thoracic Oncology , Developmental Therapeutics , Georgetown University , Lombardi Cancer Center , International Association , Lung Cancer ,